2,5-dimethyl-2H-benzotriazole | 26271-22-7

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯并三唑类
• 英文名称: 2,5-dimethyl-2H-benzotriazole
• 英文别名: 2,5-Dimethyl-2H-benzotriazol；2,5-Dimethylbenzotriazol；2,5-Dimethyl-2H-benzo[d][1,2,3]triazole；2,5-dimethylbenzotriazole
• CAS: 26271-22-7
• 化学式: C₈H₉N₃
• 分子量: 147.18
• InChiKey: XFMKHBNWJKZGDB-UHFFFAOYSA-N

物化性质

• 沸点：
  117 °C(Press: 12 Torr)
• 密度：
  1.19±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2
• 重原子数：
  11
• 可旋转键数：
  0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.25
• 拓扑面积：
  30.7
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  2,5-dimethyl-2H-benzotriazole 在 盐酸 、 水 、 硝酸 作用下， 生成 4,5,6,7-tetrachloro-2-methyl-2H-benzotriazole
  参考文献：
  名称：

  Wiley; Hussung, Journal of the American Chemical Society, 1957, vol. 79, p. 4395,4399

  摘要：

  DOI：
• 作为产物：
  描述：

  重氮甲烷 、 5-甲基苯并三氮唑 在 乙醚 作用下， 生成 2,5-dimethyl-2H-benzotriazole
  参考文献：
  名称：

  Wiley; Hussung, Journal of the American Chemical Society, 1957, vol. 79, p. 4395,4399

  摘要：

  DOI：

文献信息

• BICYCLIC COMPOUND
  申请人：Yamashita Tohru

  公开号：US20110263562A1

  公开（公告）日：2011-10-27

  The present invention provides to a compound having an ACC inhibitory action, which is useful as an agent for the prophylaxis or treatment of obesity, diabetes, hypertension, hyperlipidemia, cardiac failure, diabetic complications, metabolic syndrome, sarcopenia, cancer and the like, and has superior efficacy. The present invention relates to a compound represented by the formula (I): wherein each symbol is as defined in the specification.

  本发明提供了一种具有ACC抑制作用的化合物，该化合物可用作预防或治疗肥胖、糖尿病、高血压、高脂血症、心力衰竭、糖尿病并发症、代谢综合征、肌少症、癌症等的药剂，并具有优越的疗效。 本发明涉及一种由式(I)表示的化合物： 其中每个符号如规范中定义。
• [EN] INHIBITORS OF LYSINE SPECIFIC DEMETHYLASE-1<br/>[FR] INHIBITEURS DE LA DÉMÉTHYLASE 1 SPÉCIFIQUE DE LA LYSINE
  申请人：QUANTICEL PHARMACEUTICALS INC

  公开号：WO2016037005A1

  公开（公告）日：2016-03-10

  The present invention relates generally to compositions and methods for treating cancer and neoplastic disease. Provided herein are substituted heterocyclic derivative compounds and pharmaceutical compositions comprising said compounds. The subject compounds and compositions are useful for inhibition of lysine specific demethylase-1. Furthermore, the subject compounds and compositions are useful for the treatment of cancer, such as prostate cancer, breast cancer, bladder cancer, lung cancer and/or melanoma and the like.

  本发明一般涉及治疗癌症和肿瘤性疾病的组合物和方法。本文提供了替代杂环衍生物化合物和包含该化合物的药物组合物。所述化合物和组合物对于抑制赖氨酸特异性去甲基化酶-1是有用的。此外，所述化合物和组合物对于治疗癌症，如前列腺癌、乳腺癌、膀胱癌、肺癌和/或黑色素瘤等是有用的。
• [EN] NOVEL ANTIFUNGAL 5,6-DIHYDRO-4H-PYRROLO[1,2-a][1,4]BENZO- DIAZEPINES AND 6H-PYRROLO[1,2-a][1,4]BENZODIAZEPINES SUBSTITUTED WITH HETEROCYCLIC DERIVATIVES<br/>[FR] NOUVELLES 5,6-DIHYDRO-4H-PYRROLO[1,2-A][1,4]BENZODIAZÉPINES ET 6H-PYRROLO[1,2-A][1,4]BENZODIAZÉPINES SUBSTITUÉES PAR DES DÉRIVÉS HÉTÉROCYCLIQUES ANTIFONGIQUES
  申请人：JANSSEN PHARMACEUTICA NV

  公开号：WO2012150305A1

  公开（公告）日：2012-11-08

  The present invention is concerned with novel antifungal 5,6-dihydro-4H-pyrrolo- [1,2-a][1,4]benzodiazepines and 6H-pyrrolo[1,2-a][1,4]benzodiazepines substituted with heterocyclic derivatives of Formula (I) wherein R1, R2, R3, R4 and Het have the meaning defined in the claims. The compounds according to the present invention are active mainly against dermatophytes and systemic fungal infections. The invention further relates to processes for preparing such novel compounds, pharmaceutical compositions comprising said compounds as an active ingredient as well as the use of said compounds as a medicament.

  本发明涉及一种新型抗真菌5,6-二氢-4H-吡咯并[1,2-a][1,4]苯二氮杂环和6H-吡咯并[1,2-a][1,4]苯二氮杂环，其被杂环衍生物取代的化合物，其化学结构如下所示（I）式，其中R1、R2、R3、R4和Het在权利要求中定义了含义。根据本发明的化合物主要对皮肤真菌和全身真菌感染具有活性。本发明还涉及制备这种新型化合物的方法，包括将这些化合物作为活性成分的药物组合物以及将这些化合物用作药物的用途。
• NOVEL ANTIFUNGAL 5,6-DIHYDRO-4H-PYRROLO[1,2-a][1,4]BENZO-DIAZEPINES AND 6H-PYRROLO[1,2-a][1,4]BENZODIAZEPINES SUBSTITUTED WITH HETEROCYCLIC DERIVATIVES
  申请人：Meerpoel Lieven

  公开号：US20140045827A1

  公开（公告）日：2014-02-13

  The present invention is concerned with novel antifungal 5,6-dihydro-4H-pyrrolo-[1,2-a][1,4]benzodiazepines and 6H-pyrrolo[1,2-a][1,4]benzodiazepines substituted with heterocyclic derivatives of Formula (I) wherein R 1 , R 2 , R 3 , R 4 and Het have the meaning defined in the claims. The compounds according to the present invention are active mainly against dermatophytes and systemic fungal infections. The invention further relates to processes for preparing such novel compounds, pharmaceutical compositions comprising said compounds as an active ingredient as well as the use of said compounds as a medicament.

  本发明涉及一种新型抗真菌5,6-二氢-4H-吡咯并-[1,2-a][1,4]苯二氮杂环和6H-吡咯并[1,2-a][1,4]苯二氮杂环，其取代有Formula (I)中的杂环衍生物的R1、R2、R3、R4和Het的含义如权利要求中所定义。根据本发明的化合物主要对抗皮肤真菌和全身真菌感染有效。本发明还涉及制备这种新型化合物的方法，含有该化合物作为活性成分的药物组合物，以及将该化合物用作药物的用途。
• INHIBITORS OF LYSINE SPECIFIC DEMETHYLASE-1
  申请人：Quanticel Pharmaceuticals, Inc.

  公开号：US20160108046A1

  公开（公告）日：2016-04-21

  The present invention relates generally to compositions and methods for treating cancer and neoplastic disease. Provided herein are substituted heterocyclic derivative compounds and pharmaceutical compositions comprising said compounds. The subject compounds and compositions are useful for inhibition of lysine specific demethylase-1. Furthermore, the subject compounds and compositions are useful for the treatment of cancer, such as prostate cancer, breast cancer, bladder cancer, lung cancer and/or melanoma and the like.

  本发明一般涉及用于治疗癌症和肿瘤疾病的组合物和方法。本文提供了替代杂环衍生物化合物和包含该化合物的制药组合物。该化合物和组合物对于抑制赖氨酸特异性去甲基化酶-1具有有用性。此外，该化合物和组合物对于治疗癌症，如前列腺癌、乳腺癌、膀胱癌、肺癌和/或黑色素瘤等有用。